Caliway Biopharmaceuticals Co., Ltd. (TPE:6919)
Taiwan
· Delayed Price · Currency is TWD 611.00
+10.00 (1.66%)
At close: Dec 2, 2024, 1:30 PM CST
TPE:6919 Market Cap
TPE:6919 has a market cap or net worth of 188.45 billion as of July 14, 2025. Its market cap has increased by 179.27% in one year.
Market Cap
188.45B
Enterprise Value
178.91B
Revenue
40.47M
Ranking
n/a
PE Ratio
n/a
Stock Price
611.00
Market Cap Chart
Since December 26, 2022, TPE:6919's market cap has increased from 7.96B to 188.45B, an increase of 2,267.92%. That is a compound annual growth rate of 247.19%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 11, 2025 | 188.45B | 99.70% |
| Dec 31, 2024 | 94.36B | 300.87% |
| Dec 29, 2023 | 23.54B | 212.69% |
| Dec 30, 2022 | 7.53B | -5.41% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| PharmaEssentia | 174.63B |
| Bora Pharmaceuticals Co., LTD. | 86.16B |
| Lotus Pharmaceutical | 56.28B |
| Polaris Group | 29.28B |
| Oneness Biotech | 29.27B |
| Center Laboratories | 26.92B |
| Lumosa Therapeutics | 23.63B |
| TaiMed Biologics | 23.08B |